Accelerated Monoclonal Antibody Development: Advance From Transfection To GMP Drug Substance In 9 Months

Hear from some of the experts who were instrumental in developing the Accelerated mAb development program and work with our biotech clients on a daily basis to accelerate their timelines toward the production of GMP drug substances.

In this webinar, you will learn:

• The strategies used in the Accelerated mAb development program that allow clients to rapidly advance to GMP drug substance production with confidence
• The time and cost savings that can be achieved using streamlined unit operations and scale-up processes
• How the analytical package was designed to be phase-appropriate and accelerate timelines